close

Enter

Log in using OpenID

Candidiasis Market Upcoming Trends, Demand and Analysis Till 2026

embed
Candidiasis is a type of infection caused due to candida—an yeast and also classified as fungus, which is present in the human body. It is usually present in places like mouth, belly, and on the skin. The overgrowth of these leads to an infection. T
Candidiasis Market Upcoming Trends, Demand and
Analysis Till 2026
Candidiasis Market – Global Industry Insights, Trends, Outlook, and Opportunity
Analysis, 2018-2026
Candidiasis is a type of infection caused due to candida—an yeast and also classified as fungus, which
is present in the human body. It is usually present in places like mouth, belly, and on the skin. The
overgrowth of these leads to an infection. This dormant yeast can lead to candida infection at any stage
in a person’s life and is closely linked to the immunity level of the person. There are various types of
infections caused due to candidiasis, such as thrush/ oropharyngeal candidiasis, genital yeast infection/
invasive infection, and cutaneous candidiasis.
Thrush/ oropharyngeal candidiasis affects the mouth or throat; genital yeast infection affects the
vagina; and cutaneous candidiasis is the infection of the skin. When the infection enters into the blood
stream, the condition is called Candidemia. Candidiasis can be diagnosed by physical observation.
These conditions are usually treated using over-the-counter antifungal medicines and also specific
prescription-based antifungal medicines. Increasing consumer awareness about candidiasis and
growing number of treatment options are major factors fueling growth of the Candidiasis Market.
Rising awareness regarding the infection and increasing patient pool to favor the growth of
Candidiasis market
Rising awareness about the infections is expected to cause the growth of candidiasis market. Increasing
focus of various governments in the APAC region, such as in highly populous China and India, on
improving the healthcare infrastructure, along with increasing consumer awareness about the condition
is expected to position the region on a high growth trajectory in the global candidiasis industry over the
forecast period (2016–2024). Candidiasis are treated using various treatment option such as oral
medication, injection, and ointments.
Candidiasis can infect males, females and also newborn babies. The condition is notoriously hard to
treat in people suffering from diabetes, cancer, AIDS, and also pregnant women. As per stats released
by Centers for Disease Control and Prevention (CDC), around 75% of would suffer from at least one
vaginal candida infection in their whole life, while 40-45% would suffer twice or more. Furthermore,
46,000 cases of invasive candidiasis are reported each year in the U.S. High costs of antifungal drugs
and also the poor results of these drugs inhibit market growth, especially in cost-sensitive emerging
economies.
Candidiasis Market Taxonomy:
This market is segmented by as followsBy Route of Administration
•Oral
•Parenteral
•Topical
By Type of Infection
•Thrush/ oropharyngeal candidiasis
•Genital Yeast Infection/ Invasive infection
•Cutaneous Candidiasis
By Drug Type
•Polyene
•Azole
•Allylamines
•Miscellaneous
The major market players in Candidiasis market are Bayer, Teva Pharmaceuticals, Stellar Pharma,
Pfizer, Wockhardt, Glenmark Pharmaceuticals, Ranbaxy, Taro Pharmaceuticals, and Bristol
Laboratories, among others.
Developed Regions Growth Engine of Candidiasis Market
In developed countries, increasing number of organ transplantation, use of catheters, artificial valves,
and joints causing to growth of candida infection. The North America and Europe regions account for
the largest market share, due to high awareness about the infection, wide availability of treatment and
easy access to OTC antifungal drugs creates a highly conducive environment for growth of the market.
Ask For a Sample Copy of This Business Report :
https://www.coherentmarketinsights.com/insight/request-sample/229
Azole Drugs holds large market share, with products such as Vfend, Noxafil, and Diflucan being highly
preferred among the masses. In December 2016, Lupin Ltd. launched Voriconazole Tablets, 50 mg &
200 mg and Voriconazole Oral Suspension, 40 mg/mL as substitutes for PF Prism C.V’s Vfend Tablets,
50 mg & 200 mg and Vfend Oral Suspension, 40 mg/mL. PF Prism C.V holds a patent for its highly
effective Vfend drug. Allylamines drugs are expected to experience a positive growth curve in the near
future, with various products in the pipeline. These drugs plays an important role in preventing skin
infection. The Polyene segment growth is not positive due to absence of new product development in
the recent past and also wide availability of generic substitutes.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends, technologies, and potential
absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1–206–701–6702
Email: [email protected]
Author
ravikiran
ravikiran298   documents Email
Document
Category
Health and Medicine
Views
3
File Size
375 KB
Tags
market
1/--pages
Report inappropriate content